Cardiac SPECT With Rotating Slant Hole Collimator - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

May 18, 2006

Last Updated Date

January 3, 2007

Start Date ^†

October 2006

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

Complete list of historical versions of study NCT00328315 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Cardiac SPECT With Rotating Slant Hole Collimator

Official Title ^†

Brief Summary

The goal is to conduct a clinical pilot study to evaluate the use of a rotating multi-segment slant-hole collimator in the detection of myocardial defects.

Detailed Description

Myocardial perfusion SPECT is recognized as an effective clinical diagnostic imaging technique in the assessment of myocardial perfusion and coronary artery diseases. It is the most important clinical application of SPECT imaging techniques.

The goal is to conduct a clinical pilot study to evaluate the use of RMSSH SPECT in the detection of myocardial defects especially in very sick patients in the nuclear medicine clinics, emergence room, and intensive care units. Comparison of the clinical utilities of the cardiac RMSSH SPECT technique with conventional cardiac planar and SPECT with parallel-hole collimation will also allow us to evaluate the potential application of the technique to a wider patient population.

The objective of this study is to test the hypothesis that quantitative 99mTc myocardial perfusion RMSSH SPECT provides similar diagnostic accuracy in patients with cardiac diseases as conventional SPECT imaging techniques.

Study Phase

Study Type ^†

Observational

Study Design ^†

Screening, Longitudinal, Defined Population, Prospective Study

Condition ^†

Coronary Artery Diseases
Chest Pain

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Recruiting

Enrollment ^†

Completion Date

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Males and Females 18-80 who are scheduled for a clinical Cardiac Stress Test

Exclusion Criteria:

Pregnant Women and Children

Gender

Both

Ages

18 Years to 80 Years

Accepts Healthy Volunteers

Yes

Contacts ^††

Contact: Linda Wilkins, RT, CCRP

410-955-8216

lwilkins@jhmi.edu

Location Countries ^†

United States

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00328315

Responsible Party

Secondary IDs ^††

Study Sponsor ^†

Johns Hopkins University

Collaborators ^††

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Investigators ^†

Principal Investigator:

Benjamin Tsui, Ph.D.

Johns Hopkins University

Information Provided By

Johns Hopkins University

Verification Date

January 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.